- Filed
- Dec 8, 2023 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q3 2024 · Nov 3, 2023 | $58.11M |
| Cash And Equivalents | Q3 2024 · Feb 3, 2023 | $143.52M |
| Current Liabilities | Q3 2024 · Nov 3, 2023 | $198.76M |
| Current Liabilities | Q3 2024 · Feb 3, 2023 | $245.58M |
| Total Liabilities | Q3 2024 · Nov 3, 2023 | $222.21M |
| Total Liabilities | Q3 2024 · Feb 3, 2023 | $282.91M |
| Current Assets | Q3 2024 · Nov 3, 2023 | $127.64M |
| Current Assets | Q3 2024 · Feb 3, 2023 | $234.29M |
| Total Assets | Q3 2024 · Nov 3, 2023 | $719.95M |
| Total Assets | Q3 2024 · Feb 3, 2023 | $840.87M |
| Shares Diluted | Q3 2024 · Oct 28, 2022 | 84.58M sh |
| Shares Diluted | Q3 2024 · Oct 28, 2022 | 84.28M sh |
| Capex | Q3 2024 · Oct 28, 2022 | $1.61M |
| Operating Cash Flow | Q3 2024 · Oct 28, 2022 | −$68.18M |
| Stockholders Equity | Q3 2024 · Oct 28, 2022 | $585.9M |
| Stockholders Equity | Q3 2024 · Jul 29, 2022 | $607.59M |
| Stockholders Equity | Q3 2024 · Jan 28, 2022 | $648.06M |
| Eps Diluted | Q3 2024 · Oct 28, 2022 | −$0.33 |
| Eps Diluted | Q3 2024 · Oct 28, 2022 | −$0.88 |
| Eps Basic | Q3 2024 · Oct 28, 2022 | −$0.33 |
| Eps Basic | Q3 2024 · Oct 28, 2022 | −$0.88 |
| Rd Expense | Q3 2024 · Oct 28, 2022 | $35.26M |
| Rd Expense | Q3 2024 · Oct 28, 2022 | $102.23M |
| Net Income | Q3 2024 · Oct 28, 2022 | −$28.15M |
| Net Income | Q3 2024 · Oct 28, 2022 | −$74.46M |
| Operating Income | Q3 2024 · Oct 28, 2022 | −$36.01M |
| Operating Income | Q3 2024 · Oct 28, 2022 | −$94.61M |
| Gross Profit | Q3 2024 · Oct 28, 2022 | $65.36M |
| Gross Profit | Q3 2024 · Oct 28, 2022 | $203.55M |
| Revenue | Q3 2024 · Oct 28, 2022 | $110.94M |
| Revenue | Q3 2024 · Oct 28, 2022 | $348.14M |